Osaic Holdings’s VIVEVE MED INC VIVE Stock Holding History

Osaic Holdings’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,500	Closed	-$3K	–	7702
2022 Q4	$3K	Buy	5,500 +3,000	+120%	+$1.51K	﹤0.01%	6579
2022 Q3	$2K	Buy	2,500 +800	+47%	+$600	﹤0.01%	6906
2022 Q2	$1K	Hold	1,700	–	–	﹤0.01%	7242
2022 Q1	$2K	Hold	1,700	–	–	﹤0.01%	6957
2021 Q4	$2K	Sell	1,700 -850	-33%	-$1.56K	﹤0.01%	7101
2021 Q3	$6K	Buy	2,550 +50	+2%	+$126	﹤0.01%	6494
2021 Q2	$7K	Hold	2,500	–	–	﹤0.01%	6276
2021 Q1	$8K	Buy	+2,500	New	+$9.18K	﹤0.01%	6003
2020 Q4	–	Sell	-1,690	Closed	-$9K	–	6687
2020 Q3	$9K	Buy	+1,690	New	+$9.76K	﹤0.01%	5354

Other funds holding VIVE

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Osaic Holdings's VIVE Position: Q1 2023 in Review

Osaic Holdings sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 5,500 shares — an estimated $3K sold.

Osaic Holdings first reported a position in VIVE in Q3 2020 and held it in 9 quarters. The position peaked at $9K in Q3 2020. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.

Osaic Holdings reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
Osaic Holdings sold 5,500 VIVEVE MED INC shares in Q1 2023, an estimated $3K.
Osaic Holdings first reported a position in VIVEVE MED INC in Q3 2020 and held it in 9 quarters.
Osaic Holdings's VIVEVE MED INC position peaked at $9K in Q3 2020.
1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.